LGL Group (LGL) Projected to Post Quarterly Earnings on Monday

LGL Group (NYSEAMERICAN:LGL) is expected to be posting its Q4 2025 results after the market closes on Monday, March 30th. Analysts expect LGL Group to post earnings of $0.0651 per share and revenue of $9.10 million for the quarter. Investors may visit the the company’s upcoming Q4 2025 earning results page for the latest details on the call scheduled for Friday, April 3, 2026 at 4:00 PM ET.

LGL Group Stock Down 1.0%

Shares of NYSEAMERICAN:LGL opened at $7.19 on Friday. LGL Group has a 52 week low of $5.45 and a 52 week high of $9.74. The stock has a market capitalization of $46.95 million, a P/E ratio of 42.30 and a beta of 0.31. The firm has a fifty day simple moving average of $7.12 and a two-hundred day simple moving average of $6.48.

Insider Activity at LGL Group

In other LGL Group news, major shareholder Mario J. Gabelli purchased 95,387 shares of the stock in a transaction that occurred on Tuesday, December 30th. The stock was purchased at an average price of $4.75 per share, with a total value of $453,088.25. Following the acquisition, the insider owned 572,324 shares in the company, valued at approximately $2,718,539. The trade was a 20.00% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Insiders own 18.90% of the company’s stock.

Institutional Investors Weigh In On LGL Group

An institutional investor recently raised its position in LGL Group stock. Osaic Holdings Inc. grew its stake in LGL Group, Inc. (The) (NYSEAMERICAN:LGL) by 15.5% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 20,250 shares of the industrial products company’s stock after purchasing an additional 2,710 shares during the period. Osaic Holdings Inc. owned approximately 0.38% of LGL Group worth $154,000 at the end of the most recent reporting period. 30.28% of the stock is owned by hedge funds and other institutional investors.

LGL Group Company Profile

LGL Group Inc is a United States–based company specializing in the development and commercialization of digital pathology and molecular imaging systems for research and clinical laboratories. The company’s core focus lies in enabling high-resolution visualization and quantitative analysis of tissue samples, helping scientists and pathologists accelerate biomarker discovery and diagnostic workflows. LGL Group’s platform combines advanced optics, automated slide scanning and image analysis software to deliver end-to-end solutions tailored to oncology, immunology and neuroscience research.

The company’s flagship offerings include whole-slide scanners capable of rapid, high-throughput scanning at resolutions suited for detailed morphometric and fluorescence studies.